Summit Global Investments Vericel Corp Transaction History
Summit Global Investments
- $1.37 Billion
- Q1 2025
A detailed history of Summit Global Investments transactions in Vericel Corp stock. As of the latest transaction made, Summit Global Investments holds 11,663 shares of VCEL stock, worth $480,865. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,663
Previous 12,168
4.15%
Holding current value
$480,865
Previous $668,000
22.16%
% of portfolio
0.04%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding VCEL
# of Institutions
290Shares Held
49.5MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$332 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$144 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$133 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$99.1 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$92.3 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.95B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...